Tag: raw materials

Framework for Investigating Residual Solvent Excursions in Stability Studies In the world of pharmaceutical manufacturing, excursions noted during stability studies can impinge on the integrity of active pharmaceutical ingredients (APIs)…

Addressing Residual Solvent Excursions During Regulatory Inspections: A Comprehensive Investigation Framework Residual solvent excursions can pose significant challenges during regulatory inspections, often leading to non-compliance issues that may affect product…

Investigating API Stability Failures During Stability Studies and Strategies for Prevention In the pharmaceutical industry, managing the stability of Active Pharmaceutical Ingredients (APIs) during stability studies is critical to ensuring…

Addressing Variability in API Assay During Supplier Transitions: A Structured Investigation Approach In the ever-evolving pharmaceutical landscape, maintaining the integrity of Active Pharmaceutical Ingredients (APIs) is critical, especially during supplier…

Assessing API Stability Failures During Incoming Testing: An Investigative Approach Pharmaceutical manufacturers often encounter challenges during incoming testing of active pharmaceutical ingredients (APIs), notably with stability failures that can impact…

Framework for Investigating API Stability Failures During Stability Studies API stability failures during stability studies can pose significant challenges for pharmaceutical manufacturers, affecting product release and regulatory compliance. Identifying the…

Framework for Investigating API Stability Failures during Incoming Testing Natural variability in Active Pharmaceutical Ingredients (APIs) can pose significant challenges in ensuring quality and compliance, especially during incoming testing. A…

Framework for Investigating Polymorphic Form Inconsistency During Supplier Changes In pharmaceutical manufacturing, the inconsistency in polymorphic forms during supplier changes can lead to significant quality challenges. When a new supplier…

Addressing API Stability Failures During Regulatory Inspections API stability failures that surface during regulatory inspections can create significant disruptions in pharmaceutical manufacturing. Such scenarios not only jeopardize compliance but also…

Framework for Investigating API Stability Failures Amid Supplier Changes In the fast-evolving pharmaceutical landscape, changes in suppliers for Active Pharmaceutical Ingredients (APIs) can lead to significant challenges, particularly concerning API…

Framework for Investigating Polymorphic Form Inconsistency in Pharmaceuticals Polymorphic form inconsistency poses significant risks in pharmaceutical manufacturing, particularly concerning active pharmaceutical ingredients (APIs) and their performance. When encountering deviations related…

Assessing the Impact of API Stability Failures During Regulatory Inspections Suboptimal stability of Active Pharmaceutical Ingredients (APIs) is a critical issue that can arise unexpectedly during regulatory inspections, leading to…